armillaridin has been researched along with cycloheximide in 2 studies
| Studies (armillaridin) | Trials (armillaridin) | Recent Studies (post-2010) (armillaridin) | Studies (cycloheximide) | Trials (cycloheximide) | Recent Studies (post-2010) (cycloheximide) |
|---|---|---|---|---|---|
| 7 | 0 | 6 | 19,109 | 6 | 861 |
| Protein | Taxonomy | armillaridin (IC50) | cycloheximide (IC50) |
|---|---|---|---|
| COUP transcription factor 2 isoform a | Homo sapiens (human) | 1.315 | |
| Glucose transporter | Leishmania mexicana | 0.242 | |
| Hexose transporter 1 | Plasmodium falciparum (malaria parasite P. falciparum) | 0.31 | |
| Solute carrier family 2, facilitated glucose transporter member 1 | Homo sapiens (human) | 0.228 | |
| Eukaryotic initiation factor 4A-I | Homo sapiens (human) | 0.139 | |
| Peptidyl-prolyl cis-trans isomerase FKBP1A | Homo sapiens (human) | 3.6 | |
| Hypoxia-inducible factor 1-alpha | Homo sapiens (human) | 0.036 | |
| Endothelial PAS domain-containing protein 1 | Homo sapiens (human) | 0.036 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bohnert, M; Dahse, HM; Hoffmeister, D; Miethbauer, S; Nett, M; Ziemen, J | 1 |
| Bohnert, M; Dahse, HM; Hoffmeister, D; König, S; Scherer, O; Werz, O; Wiechmann, K | 1 |
2 other study(ies) available for armillaridin and cycloheximide
| Article | Year |
|---|---|
In vitro cytotoxicity of melleolide antibiotics: structural and mechanistic aspects.
Topics: Anti-Bacterial Agents; Basidiomycota; Cell Line, Tumor; DNA; Humans; In Vitro Techniques; Magnetic Resonance Spectroscopy; Molecular Structure; Salicylates; Sesquiterpenes | 2011 |
Melleolides induce rapid cell death in human primary monocytes and cancer cells.
Topics: Apoptosis; Cell Survival; Cells, Cultured; HeLa Cells; Humans; K562 Cells; Microscopy; Monocytes; Oligopeptides; Staurosporine; Structure-Activity Relationship | 2014 |